Determination and Pharmacokinetic Profiles of Four Active Components From Scrophularia ningpoensis Hemsl. in Rats

by Shunbin Luo, Lingping Xie, Jingjing Chen, Congrong Tang, Ren-ai Xu
Published 2021-01-01

Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS

by Tian Lan, Ping Fang, Xuemei Ye, Xia Lan, Ren-ai Xu
Published 2021-01-01

Analytical methodology and pharmacokinetic study of elagolix in plasma of rats using a newly developed UPLC-MS/MS assay

by Qiong Wang, Er-Min Gu, Chaojie Chen, Ren-ai Xu, Shunbin Luo
Published 2021-07-01

A Novel UPLC-MS/MS Assay for the Measurement of Linezolid and its Metabolite PNU-142300 in Human Serum and its Application to Patients With Renal Insufficiency

by Yingying Wang, Er-min Gu, Xiaoxiang Du, Ren-ai Xu, Guanyang Lin
Published 2021-05-01

Evaluation of the inhibitory effect of quercetin on the pharmacokinetics of tucatinib in rats by a novel UPLC–MS/MS assay

by Ying Zhang, Ya-nan Liu, Saili Xie, Xuegu Xu, Ren-ai Xu
Published 2022-12-01

Effect of Sophocarpine on the Pharmacokinetics of Umbralisib in Rat Plasma Using a Novel UPLC-MS/MS Method

by Qinghua Weng, Xia Lan, Yingjie Wang, Chen Fan, Ren-ai Xu, Pengzhao Zhang
Published 2022-01-01

Inhibitory effect of propafenone on vortioxetine metabolism in vitro and in vivo

by Ren-ai Xu, Shunbin Luo, Qianmeng Lin, Yuanyuan Shao, Chaojie Chen, Xuemei Ye
Published 2021-05-01

Quantitative investigation of drug-drug interaction between bergenin and vilazodone in rats through UPLC-MS/MS assay

by Mengming Xia, Xinhao Xu, Chaojie Chen, Hualu Wu, Ren-ai Xu, Changlv Wang
Published 2024-05-01

In vivo Pharmacokinetic Drug-Drug Interaction Studies Between Fedratinib and Antifungal Agents Based on a Newly Developed and Validated UPLC/MS-MS Method

by Congrong Tang, Xiaohui Niu, Lu Shi, Huidan Zhu, Guanyang Lin, Ren-ai Xu
Published 2021-02-01

UPLC-MS/MS for simultaneous quantification of vortioxetine and its metabolite Lu AA34443 in rat plasma and its application to drug interactions

by Er-Min Gu, Yuanyuan Shao, Wei-Feng Xu, Lei Ye, Ren-ai Xu
Published 2020-11-01

A Reliable and Effective UPLC-MS/MS Method for the Determination of Oprozomib in Rat Plasma

by Xia Li, Ya-nan Liu, En Zhang, Ren-ai Xu, Tingyong Yang, Shunbin Luo
Published 2023-01-01

Effects of CYP2C19 variants on the metabolism of tapentadol in vitro

by Ren-ai Xu, Ping Fang, Zhize Ye, Mingming Han, Jian-Ping Cai, Guoxin Hu
Published 2022-05-01

Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research

by Jingjing Nie, Jingjing Nie, Hailun Xia, Ya-Nan Liu, Yige Yu, Ren-Ai Xu
Published 2023-11-01

Effects of salidroside on rat CYP enzymes by a cocktail of probe drugs

by Yan-Li Wei, Hong-Jian Du, Yi-Ping Lin, Mei-Ling Wu, Ren-ai Xu
Published 2018-04-01

Establishment and validation of a UPLC-MS/MS bioassay for the quantification of infigratinib in rat plasma

by Xuegu Xu, Chaojie Chen, Ya-nan Liu, Xiaolei Meng, Jian-ping Cai, Ren-ai Xu
Published 2022-07-01

Development and validation of the quantitative determination of avapritinib in rat plasma by a bioanalytical method of UPLC-MS/MS

by Xuegu Xu, Shunbin Luo, Qiang Yang, Yingjie Wang, Wenlong Li, Guanyang Lin, Ren-ai Xu
Published 2021-06-01

Simultaneous measurement of COVID-19 treatment drugs (nirmatrelvir and ritonavir) in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study

by Chen-Jian Zhou, Ya-nan Liu, Anzhou Wang, Hualu Wu, Ren-ai Xu, Qiang Zhang
Published 2024-06-01

Characterization of Alpelisib in Rat Plasma by a Newly Developed UPLC-MS/MS Method: Application to a Drug-Drug Interaction Study

by Qiong Wang, Xia Lan, Zhuofei Zhao, Xiaohang Su, Yuji Zhang, Xiao-Yang Zhou, Ren-Ai Xu
Published 2021-11-01

Lack of pharmacokinetic interaction between derazantinib and naringin in rats

by Ya-nan Liu, Jie Chen, Xinhao Xu, Yingying Hu, Jin-yu Hu, Ren-ai Xu, Guanyang Lin
Published 2023-12-01

Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles

by Shun-bin Luo, Er-min Gu, Yu-ao Chen, Shi-chen Zhou, Chen Fan, Ren-ai Xu
Published 2022-01-01